Home › DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on...
 

Keywords :   


DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on...

2015-09-10 15:12:57| Logistics - Topix.net

DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today presented updated clinical data from its Phase I/II study of lead product candidate VAL-083 , in patients with refractory glioblastoma multiforme , at GBM2015 : 2 International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain. The Company's data was presented in a poster entitled, "Update on Phase I/II study of VAL-083 in patients with recurrent malignant glioma."

Tags: data updated iii phase

Category:Transportation and Logistics

Latest from this category

All news
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Summary for Hurricane Kirk (AT2/AL122024)
04.10Hurricane Kirk Public Advisory Number 22
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
Transportation and Logistics »
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »